Product Information
DOXYCYCLINE MONO 50 MG CAP is a generic product labeled by Strides Pharma Inc., priced at $0.1517 per EA under NDC 64380017901. Its NADAC has been published 201 times since Aug 31, 2022.
FDA first approved this application on Dec 1, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380017901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA065055FDA Approved
12/1/2000
TE Code
AB
On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE MONO 50 MG CAP has been published 201 times since Aug 31, 2022, and over the history we have for it it has declined 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1517 per EA |
|---|---|
| All-time high | $0.1946 (Jun 14, 2023) |
| All-time low | $0.1412 (Jul 17, 2024) |
| 52-week high | $0.1657 |
| 52-week low | $0.1502 |
| Median price | $0.1627 |
| Average price | $0.1650 |
| Largest weekly change | +20.4% (Aug 21, 2024) |
| Weeks tracked | 201 |
| Tracking since | Aug 31, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
doxycycline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE MONO 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 50 MG CAP, manufactured by Strides Pharma Inc., is $0.1517 per EA (NDC 64380017901), effective Sep 30, 2026.
How has the price of DOXYCYCLINE MONO 50 MG CAP changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE MONO 50 MG CAP has declined 18.9%. It has been tracked across 201 weekly CMS publications since Aug 31, 2022.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 50 MG CAP?
Since Aug 31, 2022, the NADAC for DOXYCYCLINE MONO 50 MG CAP has ranged from a low of $0.1412 (Jul 17, 2024) to a high of $0.1946 (Jun 14, 2023), with a median of $0.1627 per EA.
Are there cheaper alternatives to DOXYCYCLINE MONO 50 MG CAP?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXYCYCLINE MONO 50 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYCYCLINE MONO 50 MG CAP?
DOXYCYCLINE MONO 50 MG CAP (NDC 64380017901) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.